Yang Y - Search Results

1

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2).

Zhao WH, Wang BY, Chen LJ, Fu WJ, Xu J, Liu J, Jin SW, Chen YX, Cao XM, Yang Y, Zhang YL, Wang FX, Zhang PY, Lei B, Gu LF, Wang JL, Zhang H, Bai J, Xu Y, Zhu H, Du J, Jiang H, Fan XH, Li JY, Hou J, Chen Z, Zhang WG, Mi JQ, Chen SJ, He AL. Zhao WH, et al. Among authors: yang y. J Hematol Oncol. 2022 Jul 6;15(1):86. doi: 10.1186/s13045-022-01301-8. J Hematol Oncol. 2022. PMID: 35794616 Free PMC article. Clinical Trial.

2

A phase-I clinical trial of active immunotherapy for acute leukemia using inactivated autologous leukemia cells mixed with IL-2, GM-CSF, and IL-6.

Zhang WG, Liu SH, Cao XM, Cheng YX, Ma XR, Yang Y, Wang YL. Zhang WG, et al. Among authors: yang y. Leuk Res. 2005 Jan;29(1):3-9. doi: 10.1016/j.leukres.2004.04.015. Leuk Res. 2005. PMID: 15541469 Clinical Trial.

3

[Positive immunoregulation of thalidomide on human peripheral blood mononuclear cell cultures].

Yang Y, Zhang WG, Chen YX, Cao XM, He AL, Yang HY, Tian W. Yang Y, et al. Among authors: yang hy. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Dec;14(6):1172-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 17204188 Chinese.

4

Indoleamine 2, 3-dioxygenase expression in cells of human acute monocyte leukemia (M(5)) and acute lymphocyte leukemia and therapeutic effect of its inhibitor 1-methyl tryptophan.

Sun JX, Zhang WG, Chen YX, Zhao WH, Tian W, Yang Y, Liu SH. Sun JX, et al. Among authors: yang y. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Jun;15(3):478-82. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007. PMID: 17605849

5

[Effects of thalidomide on CD4(+)CD25(+) T regulatory cells in patients with multiple myeloma].

Yang Y, Zhang WG, He AL, Yang HY, Wang JL, Tian W. Yang Y, et al. Among authors: yang hy. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Jun;16(3):538-42. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18549624 Chinese.

6

[Efficacy of different thalidomide regimens for patients with multiple myeloma and its relationship with TNF-alpha level].

Ma XR, Chen YX, Liu J, Zhang WG, Cao XM, He AL, Yang Y. Ma XR, et al. Among authors: yang y. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1312-5. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 19099634 Clinical Trial. Chinese.

7

[Regulatory effect of thalidomide on the expression of costimulatory molecules in patients with multiple myeloma].

Yang Y, Zhang WG, He AL, Yang HY, Wang Y, Tian W. Yang Y, et al. Among authors: yang hy. Nan Fang Yi Ke Da Xue Xue Bao. 2009 Dec;29(12):2470-2, 2476. Nan Fang Yi Ke Da Xue Xue Bao. 2009. PMID: 20034904 Chinese.

8

Anti-tumor immune responses in immune-reconstituted mice injected with a tumor vaccine.

He A, Zhang W, Xu K, Wang J, Yang Y, Chao X. He A, et al. Among authors: yang y. Med Oncol. 2012 Sep;29(3):2261-9. doi: 10.1007/s12032-011-0024-8. Epub 2011 Jul 15. Med Oncol. 2012. PMID: 21761245

9

Detection of serum tumor markers in multiple myeloma using the CLINPROT system.

He A, Bai J, Huang C, Yang J, Zhang W, Wang J, Yang Y, Zhang P, Zhou F. He A, et al. Among authors: yang y, yang j. Int J Hematol. 2012 Jun;95(6):668-74. doi: 10.1007/s12185-012-1080-3. Epub 2012 Apr 27. Int J Hematol. 2012. PMID: 22539364

10

Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling.

Bai J, He A, Zhang W, Huang C, Yang J, Yang Y, Wang J, Zhang Y. Bai J, et al. Among authors: yang y, yang j. Proteome Sci. 2013 Aug 3;11:39. doi: 10.1186/1477-5956-11-39. eCollection 2013. Proteome Sci. 2013. PMID: 23915341 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100,954 results

Search Page